NCT00480558View on ClinicalTrials.gov

A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
HIV InfectionsTB
Interventions
BIOLOGICAL

MVA 85A

Modified vaccinia Ankara virus expressing antigen 85A from M. tuberculosis. Dose is 5x10\^7

Trial Locations (1)

Unknown

University Cape Town, Cape Town

All Listed Sponsors
collaborator

University of Cape Town

OTHER

lead

University of Oxford

OTHER

NCT00480558 - A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both | Biotech Hunter | Biotech Hunter